Pharmaceuticals News

Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.

BioPharm Systems to Host Webinar on Sharing CTMS Data Between Sponsors and CROs

Leading provider of Oracle's clinical trial, data, safety, and pharmacovigilance systems will discuss the trend of outsourcing clinical trial management, as well as the various approaches to sharing CTMS data between sponsors and CROs. - May 18, 2012 - BioPharm Systems

Dr. Toufigh Gordi to Discuss Pediatric PK Model in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”

Dr. Gordi, will present “Mechanistic PK/PD Modeling in Pediatrics” Webinar May 22, 2012. - May 18, 2012 - Rosa & Co LLC

IonSense Presenting OpenSpot Mass Spectrometry™ at the American Society for Mass Spectrometry Annual Conference

IonSense Presenting OpenSpot Mass Spectrometry™ at the American Society for Mass Spectrometry Annual Conference

OpenSpot™ Sample Cards Facilitate Simpler Analysis, Eliminating Most Consumables and Solvents, Reducing Costs and Lab Waste. Exhibited at ASMS 2012. Booth #57. - May 17, 2012 - IonSense, Inc.

Bee Health Achieve BRC Level 6 Global Food Audit Status

Bee Health today announced they have achieved the highest quality standard for Food Supplement production with Level 6 Global Food BRC approval. - May 14, 2012 - Bee Health Limited

Grand Rounds at Metropolitan Hospital - Compounding Options in Medicine: Special Focus on Physiatry

Dr Haldey, PharmD, President of Royal Care Pharmacy, Inc, will provide a comprehensive overview of pharmacy compounding with a specific focus on physiatry. - May 12, 2012 - Royal Care Pharmacy Inc

Royal Care Pharmacy Will Present at the 5th Annual Wound Symposium

Dr Emil Haldey, the Company’s President, has been invited to speak at the 5th Annual Wound Care Symposium sponsored by NY College of Podiatric Medicine and Nassau University Medical Center. Dr Emil Haldey will discuss history, rationale and benefits of pharmacy compounding for the modern podiatry practice. - May 12, 2012 - Royal Care Pharmacy Inc

Stevens Team Wins First Place in New Jersey ISPE Student Poster Competition

Diagnostic invention allows clinicians to comprehensively evaluate spinal movement - May 10, 2012 - Stevens Institute of Technology

Stevens Institute of Technology Taps M-Files ECM and Part 11 Compliance Package for their Pharmaceutical Curriculum

University Integrates M-Files into Advanced Validation Course for Pharmaceutical Students - May 09, 2012 - Stevens Institute of Technology

The Pharma Compliance Group Announces Exclusive Sales Agreement with LearnSomething, Inc. for DEA Compliance Online Training

The Pharma Compliance Group Announces Exclusive Sales Agreement with LearnSomething, Inc. for DEA Compliance Online Training

The Pharma Compliance Group (PCG) announce that it has signed an exclusive marketing and sales agreement with LearnSomething, Inc. to offer online training for the pharma industry to support DEA compliance of the CSA and CFR for pharmacists, pharmacy technicians and other DEA registrants. - May 07, 2012 - Pharma Compliance Group, LLC

Avomeen Analytical Services Opens Newly Renovated Pharmaceutical Research and Development Laboratory

Avomeen Analytical Services, an Ann Arbor, Michigan based independent testing laboratory has announced opening of newly renovated pharmaceutical research and development laboratories at its location at 6107 Jackson Rd Ann Arbor, Michigan. Avomeen’s pharmaceutical services include method... - May 05, 2012 - Avomeen Analytical Services

MedPro Rx, Inc. Named One of 50 Fastest-Growing Women-Owned Companies in North America

Specialty Pharmacy Owned by City of Raleigh, N.C. Mayor Nancy McFarlane, Recognized by American Express OPEN And Women Presidents’ Organization (WPO) - May 04, 2012 - MedPro Rx, Inc.

"World Hepatitis Treatment and Vaccine Market Will Reach $8.7bn in 2012" Visiongain Report Predicts

A new report by visiongain, a London-based business information provider, predicts that global revenues for hepatitis treatments and vaccines will reach $8.7 billion for 2012. - May 04, 2012 - visiongain

Unbound Medicine and Datapharm Launch Mobile Medicines Compendium UK - Comprehensive Database of Pharmaceutical Product Information Now Available for Mobile Download

Unbound Medicine and Datapharm Launch Mobile Medicines Compendium UK - Comprehensive Database of Pharmaceutical Product Information Now Available for Mobile Download

Unbound Medicine, a leader in knowledge management solutions for health care, and Datapharm, an independent organization dedicated to improving public health and safety by providing up-to-date, accurate and comprehensive information about medicines, announce the release of Medicines Compendium UK for mobile devices. Medicines Compendium UK represents the first mobile application with the unabridged Summary of Product Characteristics (SPCs) for more than 5,000 unique pharmaceutical products. - May 03, 2012 - Unbound Medicine

"Global Nuclear Medicine Market Will Reach $4.5bn by 2022" Visiongain Report Predicts

A new report by visiongain, a London-based business information provider, predicts that the global market for nuclear medicine will be worth $4.5bn by 2022. The market generated sales of $1.4bn in 2010. - May 03, 2012 - visiongain

Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product

Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product

pharmaCline's Diabecline antibiotic ointment has been recognized as the Bronze Award winner for Best New Pharmaceutical Product by the Edison Awards. - May 01, 2012 - pharmaCline

Ameridose Supports Pharmacy Leadership Forum

Ameridose, LLC, the leading nationwide provider of sterile admixing services to hospital pharmacies, is honored to sponsor the Executive Forum segment of Boston University School of Management’s 2012 Pharmacy Leadership Institute program. This year’s Executive Forum is titled... - May 01, 2012 - Ameridose, LLC

AdvantaPure(R) to Spotlight Molded Components & Single Use Items at Spring 2012 Trade Shows; Schedule Includes Pharmaceutical & Bioprocess Events

High purity tubing manufacturer AdvantaPure will exhibit its single use products and molded components for the pharmaceutical and bioprocess industries at two upcoming events, Interphex and the Single Use Applications Conference. AdvantaPure will highlight single use tubing of silicone and TPE and molded fitting connections. When combined into a manifold assembly, the products help reduce leaks associated with barbed-style fittings that can lead to wasted batches of costly pharmaceuticals. - April 28, 2012 - NewAge Industries, Inc.

Pharmaceutical Operations Provider, Inc. Announces Brent Galletta Has Joined Their Management Team as Vice President of Business Development

Pharmaceutical Operations Provider has brought Brent Galletta in as Vice President of Business Development to implement new sales and support strategies. These strategies include developing strong longstanding relationships with clients looking to provide their sales representatives with the most comprehensive PDMA compliant mobile sales CRM. - April 27, 2012 - Pharmaceutical Operations Provider

Foamix Obtains US Patent "Waterless Hydrophilic Foam" for Dermatological and Gynecological Drugs, Such as Antibiotics, Antifungals and Corticosteroids

Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a new patent from United States Patent Office. - April 27, 2012 - Foamix Ltd

Carotech to Share Latest Breakthrough in Tocomin SupraBio Research at SupplySide MarketPlace, New York

They will be sharing with customers and visitors the latest clinical data of their patented and bioenhanced natural full spectrum palm tocotrienol complex. - April 27, 2012 - Carotech Inc.

Ameridose Sponsors Health Connect Partners 2012 Spring Hospital Pharmacy Conference

Ameridose, LLC, the leading nationwide provider of sterile admixing services to hospital pharmacies, is pleased to be a sponsor of the Health Connect Partners Spring Hospital Pharmacy Conference for a second consecutive year. The conference will take place from May 7-9, 2012 at the Hyatt Regency in... - April 26, 2012 - Ameridose, LLC

Ameridose Unveils Innovative First Quarter Sustainability Enhancements

Ameridose, LLC, the leading nationwide provider of sterile admixing services to hospital pharmacies, is pleased to share exciting sustainability news for the first quarter of 2012. Aiming for the ultimate in energy efficiency, Ameridose is currently in the process of installing a made-in-the-USA... - April 24, 2012 - Ameridose, LLC

Increasing Cardiac Patient Base Drives the Indian Cardiovascular Pharma Market, Finds Netscribes

Netscribes (India) Pvt. Ltd., launches a report on the Cardiovascular Pharmaceuticals Market in India 2012 as part of Netscribes’ Healthcare Industry report series. - April 21, 2012 - Netscribes, Inc.

Gabbard Wellness Announces Strategic Partnership with Stark Service Solutions, LLC

New partnership makes available quality health and wellness products to the hospitality industry. - April 19, 2012 - Gabbard Wellness Group Inc.

"Smoking Cessation Drugs Market Will Reach $2.4 Billion in 2012" Visiongain Report Predicts

A new report by visiongain predicts that the world market for smoking cessation medicines will reach $2.4 billion for 2012. - April 16, 2012 - visiongain

Syndicated Columnist & Talk Show Host Sandy Zimmerman Announced an Interview with Dr. Mary Block, D.O., Regarding the Safety of Our Drugs Today

Sandy Zimmerman feels, “The public think our medicines are safe because they were approved by the FDA but what is the process of drug approval?” - April 11, 2012 - Sandy Zimmerman

GS1 EPCglobal Software Certification Mark for EPCIS Awarded to FastPoint Technologies

FastPoint Technologies is recognized as a provider of certified software solutions for Electronic Product Code Information Services (EPCIS). - April 11, 2012 - FastPoint Technologies

High Infectious Disease Incidence Drives the Indian Anti-Infective Pharma Market, Finds Netscribes

Netscribes (India) Pvt. Ltd., launches a report on the Anti-Infective Pharmaceuticals Market in India 2012 as part of Netscribes’ Healthcare Industry report series. - April 08, 2012 - Netscribes, Inc.

Dr. Birgit Schoeberl to Discuss Using Mathematical Models to Set Design Criteria for Antibody-Based Therapies in Rosa’s "Impact" World-Wide Webinar Series

Dr. Schoeberl will present “Using Mathematical Models To Set Design Criteria For Antibody-Based Therapies” April 17, 2012. - April 04, 2012 - Rosa & Co LLC

Indian Anti-Diabetic Pharma Market is Largely Driven by Huge Diabetic Patient Base, Finds Netscribes

Netscribes (India) Pvt. Ltd., launches a report on the Anti-Diabetic Pharmaceuticals Market in India 2012 as part of Netscribes’ Healthcare Industry report series. - April 01, 2012 - Netscribes, Inc.

Rosa to Present Two Lectures at the European Foundation of Medicinal Chemists Conference

Rosa to Present The MQM Standard and Lead Optimization Using Systems Pharmacology Modeling - April 01, 2012 - Rosa & Co LLC

"Eleven Indian Companies in the Top 50 Generics Manufacturers Worldwide" States Visiongain Report

A new report by visiongain lists 11 Indian companies among the top 50 generic drug manufacturers worldwide. Five Indian companies (Ranbaxy, Cipla, Dr. Reddy’s, Sun Pharma and Lupin) are in the top 20, the joint-highest representation for any country. While Teva remains the largest player in the industry, with revenues of over $10bn for its generics portfolio in 2011, the competition is growing ever more intense. - March 29, 2012 - visiongain

Rosa to Present Systems Pharmacology Workshop at 3rd Annual World PK/PD Summit

Rosa Workshop Presents the MQM Quality Standard for Mechanistic Modeling - March 26, 2012 - Rosa & Co LLC

New Revolutionary Mental Illness Treatment Offers Hope for Multiple Disorders and is Non Evasive

New Revolutionary Mental Illness Treatment Offers Hope for Multiple Disorders and is Non Evasive

Transcranial Magnetic Stimulation Therapy (TMS) is explained by Psychiatrist Dr. Tarique Perera on Smart Health Talk Radio show, April 22 at 4:00 pm PST on KCAARadio.com. TMS can work when other treatments fail, and offers a new treatment option. - March 23, 2012 - Smart Health Talk

Medimix International and Sanofi Pasteur to Present Results of Social Media Monitoring Study  PMRG ANC - Orlando, March 27th, 2012

Medimix International and Sanofi Pasteur to Present Results of Social Media Monitoring Study PMRG ANC - Orlando, March 27th, 2012

Medimix International and Sanofi Pasteur will present at the PMRG ANC results of an innovative social media study which used a powerful new tracking platform to monitor social media conversations around the globe. Scouring sites representative of English, Spanish, French, Portuguese, German and Chinese (or 80% of the languages used by online populations), the flagged mentions were analyzed by both machine and human to correctly categorize content, overall sentiment, and identify influencers. - March 23, 2012 - Medimix International

Rising Number of Cancer Cases Making India Potential Market for Anti-Cancer Drugs, Finds Netscribes

Netscribes (India) Pvt. Ltd., launches a report on the Oncology Pharmaceuticals Market in India 2011 as part of Netscribes’ Healthcare Industry report series. - March 21, 2012 - Netscribes, Inc.

Detroit R&D and ALPCO Diagnostics Sign Distribution Agreement

Detroit R&D and ALPCO Diagnostics Sign Distribution Agreement

ALPCO Diagnostics and Detroit R&D agree to a distribution partnership in North America. - March 20, 2012 - ALPCO

Foamix’s Minocycline Foam – 100% Effective in Impetigo Phase II Clinical Trial with No Side Effects. 80% Improved Significantly After 3 Days of Treatment.

Targets a $1 billion a year market. Foamix, a clinical stage specialty pharmaceutical company, announced today the successful completion of the Phase II clinical trial of Minocycline foam in Impetigo patients. Minocycline Foam has shown to be highly effective against bacteria, including some multi-drug resistant strains (such as MRSA). - March 20, 2012 - Foamix Ltd

Paragon Innovations Helps Diabetics Cut the (Refrigerator) Cord, with Design of New Temperature Control Device

Say goodbye to coolers and ice packs. Available this summer from Kewl Innovations, amazing nano-technology-driven device will keep medicine temps consistent – for days. - March 19, 2012 - Paragon Innovations, Inc.

"Ophthalmic Drugs Market Will Reach $18.7 Billion in 2012" Visiongain Report Predicts

A new report by visiongain predicts that the world market for ophthalmic drugs will reach $18.7 billion for 2012. That revenue forecast appears in Ophthalmic Drugs: World Market Prospects 2012-2022, published in March 2012. Visiongain is a business information provider based in London, UK. - March 18, 2012 - visiongain

High Infectious Diseases Incidence Drives the Indian Anti-Infective Pharmaceutical Market, Finds Netscribes

Netscribes (India) Pvt. Ltd., launches a report on the Anti-Infective Pharmaceuticals Market in India 2011, as part of Netscribes’ Healthcare Industry report series. - March 17, 2012 - Netscribes, Inc.

Indian Anti-Diabetic Pharma Market is Largely Driven by Huge Diabetic Patient Base, Finds Netscribes

Netscribes (India) Pvt. Ltd., launches a report on the Anti-Diabetic Pharmaceuticals Market in India 2011 as part of Netscribes’ Healthcare Industry report series. - March 17, 2012 - Netscribes, Inc.

New Book  Release

New Book Release

CGMP University inc of San Jose announced the release of two books: 1. How to design a Pharmaceutical Quality system. 2. Principles of design controls for medical device. - March 16, 2012 - cGMP UNIVERSITY INC.

Dr. Joga Gobburu to Discuss the Impact of Pharmacometrics on Drug Approvals in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”

Dr. Gobburu will present “Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions” March 20, 2012. - March 16, 2012 - Rosa & Co LLC

Foamix Granted Comprehensive US Patent for PerFoam® – Ideal Foam Treatment for Head Lice and Scabies

Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a new patent from United States Patent Office. - March 15, 2012 - Foamix Ltd

The 2012 BioProcess International Awards - Honoring a Decade of BioProcess

Awarding 4 Awards in pillar of bioprocess: Upstream, downstream and manufacturing. Awards include Technology of the Decade, Technical Application of the Decade, Collaboration of the Decade, and Thought Leader of the Decade - March 14, 2012 - BioProcess International

Rising Tendencies Towards Self-Treatment Drives the Indian OTC Drug Market, Finds Netscribes

Netscribes (India) Pvt. Ltd., launches a report on the OTC Pharmaceuticals Market in India 2011 as part of Netscribes’ Healthcare Industry report series. - March 14, 2012 - Netscribes, Inc.

Foamix Obtains US Patent for Iodine Foam – Innovative Treatment for Heat Burns and Warfare Materials, as Well as Fungal and Bacterial Infection

Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a new patent from United States Patent Office. - March 13, 2012 - Foamix Ltd

New Foamix US Patent: "Foamable Compositions, Kits and Methods for Hyperhidrosis" - First in Class Foam for Excessive Sweating

Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a new patent from United States Patent Office. - March 13, 2012 - Foamix Ltd

Rosa PK/PD Collaboration with Pfizer to be Presented at ASCPT 2012

PK/PD analyses used to support the rationale for therapeutic strategies targeting myostatin pathway. - March 10, 2012 - Rosa & Co LLC

Press Releases 1,851 - 1,900 of 2,765